Clinical Case Database / Category: Patient Management

Sickle ß thalassemia and secondary prevention of stroke

Publication details

Philippa Anna Stilwell, Michele Afif
Foundation Years Journal, volume 8, issue 6, p.50 (123Doc Education, London, June 2014)

Abstract

A girl with Sickle ß Thalassemia was started on a long term transfusion programme after suffering from a stroke at the age of 7. This involves regular blood transfusions, with the aim of keeping the percentage of sickle haemoglobin (HbS%) as low as possible, ideally below 30, to reduce the risk of further strokes. Despite a combination of top up transfusions and exchange transfusions, which have allowed some control of the patient's HbS%, ischaemic changes and vascular abnormalities in her brain have deteriorated. She now awaits a stem cell transplantation. Previous international trials have demonstrated that children who have had an infarctive stroke have high risk of having a further stroke if they remain untreated. This risk can be signifiantly reduced if children are established on the transfusion programme. The transfusion programme can only be effective if the HbS% is adequately controlled, which can be difficult, as is seen in our patient. Stem cell transplantation (matched sibling donor/haploidentical) is potentially curative and offers the option for definitive secondary prevention of strokes, but is a toxic procedure and currently reserved for patients with a severe clinical course.

Access the Clinical Cases Database

A subscription is required to read the full article. Please subscribe using one of the options below.

ProductPriceSubscription
Foundation Years Clinical Cases Database£29.006 months
Add to cart
Foundation Years Clinical Cases Database£39.0012 months
Add to cart

Authors

Philippa Anna Stilwell (Corresponding author)

FY 1 Doctor, Jack's Place, Paediatrics,
Northwick Park Hospital, Watford Road,
Harrow, Middlesex, HA1 3UJ
annastilwell@gmail.com

Michele Afif

Consultant Paediatrician & Paediatric Lead for Haemoglobinopathy,
Jack's Place, Paediatrics,
Northwick Park Hospital, Watford Road, Harrow, Middlesex, HA1 3UJ
micheleafif@nhs.net

References

1.  Brousse V, Elie C, Benkerrou M, Odievre MH, Lesprit E, Bernaudin F, et al. 2012. Acute splenic sequestration crisis in sickle cell disease: cohort study of 190 paediatric patients. Br J Haematol 2012;156:643-8.

2.  Hebbel RP. 2011. Reconstructing sickle cell disease: a data-based analysis of the “hyperhemolysis paradigm” for pulmonary hypertension from the perspective of evidence-based medicine. Am J Hematol ;86:123-54.

3.  Rees DC, Williams TN, Gladwin MT. Sickle-cell disease. Lancet 2010;376:2018-31.

4.  Ohene-Frempong K, Weiner SJ, Sleeper LA, Miller ST, Embury S, Moohr JW, et al. 1998. Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood 1998;91:288-94.

5.  Switzer JA, Hess DC, Nichols FT, Adams RJ. Pathophysiology and treatment of stroke in sickle-cell disease: present and future. Lancet Neurol 2006; 5:501-12.

6.  Adams RJ, McKie VC, Hsu L, Files B, Vichinsky E, Pegelow C, et al. Prevention of a fist stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med 1998;339:5-11.

7.  Fullerton HJ, Adams RJ, Zhao S, Johnston SC. Declining stroke rates in Californian children with sickle cell disease. Blood 2004;104:336-9.

8.  Hulbert ML, McKinstry RC, Lacey JL, et al. Silent cerebral infarcts occur despite regular blood transfusion therapy after fist stroeks in children with sickle cell disease. Blood. 2011; 117(3):772-779

9.  Ware RE, Helms RW. 2012. Stroke with Transfusions Changing to Hydroxyurea (SwiTCH): A phase 3. randomised clinical trail for treatment of children with sickle cell anaemia, previous stroke and iron overload. Blood. 119: 3925-3932.

10.  DeBaun MR. 2011. Secondary Prevention of Overt Strokes in Sickle Cell disease: Therapeutic Strategies and Effiacy. Haematology 2011. American Society of Haematology.

11.  Brousse V, Makani J, Rees D. 2014. Management of sickle cell disease in the community. British Medical Journal 2014; 348:g1765.

Disclaimers

Conflict Of Interest

The Journal requires that authors disclose any potential conflict of interest that they may have. This is clearly stated in the Journal’s published “Guidelines for Authors”. The Journal follows the Guidelines against Conflict of Interest published in the Uniform Requirements for Manuscripts Submitted to Biomedical Journals (http://www.icmje.org/urm_full.pdf).

Financial Statement

The authors of this article have not been paid. The Journal is financed by subscriptions and advertising. The Journal does not receive money from any other sources. The decision to accept or refuse this article for publication was free from financial considerations and was solely the responsibility of the Editorial Panel and Editor-in-Chief.

Patient Consent statement

All pictures and investigations shown in this article are shown with the patients’ consent. We require Authors to maintain patients’ anonymity and to obtain consent to report investigations and pictures involving human subjects when anonymity may be compromised. The Journal follows the Guidelines of the Uniform Requirements for Manuscripts (http://www.icmje.org/urm_full.pdf). The Journal requires in its Guidelines for Authors a statement from Authors that “the subject gave informed consent”.

Animal & Human Rights

When reporting experiments on human subjects, the Journal requires authors to indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the HelsinkiDeclaration of 1975, as revised in 2008.

About the Clinical Cases Database

T​he Foundation Years Clinical Cases Database is​ a selection of 600 peer-reviewed clinical cases in the field of patient safety and clinical practice, specifically focused on the clinical information needs of junior doctors, based around the Foundation Year Curriculum programme (MMC). The cases have been chosen to align with the Foundation Year Curriculum.

The database is fully searchable, or can be browsed by medical specialty. Abstracts can be read free of charge, however a subscription is required in order to read the complete cases.